Clinical Evaluation 2 answers

How to demonstrate clinical equivalence for MDSW when competitor data is unavailable?

Anonymous · Published December 20, 2025 · 1 comment
We are developing a medical device software (MDSW) that appears equivalent to others already on the market. However, we do not have access to detailed technical descriptions or clinical data of these competitor devices, only published papers with results.
We have been advised to buy the competitor’s software and compare it to ours, but we find this approach questionable. Is it mandatory to acquire and compare the actual competitor device, or can published literature suffice?
Are there alternative strategies to demonstrate equivalence, and if not, how complicated is it to conduct a clinical investigation for a class IIa MDSW?

Join the discussion. Leave a comment. Guest comments are welcome — add your email to get reply notifications.

Anonymous 8 months ago
This is a common challenge for software-based medical devices. Guidance on equivalence demonstration is often unclear.
Reply to this comment

Discussion

2 Answers

Accepted answer Dr. Oliver Eidel · Founder & CEO, OpenRegulatory ·
In clinical evaluation based on equivalence, a key issue is legal access to clinical data from the equivalent device. Regulations, such as MDR, often restrict use of equivalence to devices from the same manufacturer or within the same organisation, making it hard to apply to competitor devices.
For standalone software, it's important to review MDCG 2020-1 to determine if clinical data is required, or if your evaluation can be based on the other pillars (like scientific literature and performance data).
Referring to published data from similar or potentially equivalent devices is generally feasible, but you must demonstrate sufficient access to the data according to MDR Annex XVI. In practice, this is challenging between different manufacturers.
Conducting a clinical investigation is not always mandatory for class IIa devices—it depends on classification, intended use, and available data. There is no fixed rule, so review the guidance and consider consulting your Notified Body for specific advice.

Join the discussion. Leave a comment. Guest comments are welcome — add your email to get reply notifications.

No comments yet. Be the first to share your thoughts.

A
Anonymous ·
I'm not an expert, but buying a competitor's product for equivalence isn't so unusual. When a device is offered on the market, aspects of it are considered public. The idea is to compare how it works, not to reverse engineer or copy any intellectual property. For example, with a thermometer, you would buy and compare the measurements, which seems reasonable.
However, I can't speak to whether this is required, and the regulations are not always clear. You might want to check with your Notified Body for their expectations.

Join the discussion. Leave a comment. Guest comments are welcome — add your email to get reply notifications.

No comments yet. Be the first to share your thoughts.

Want to add your answer to this question?
Write an answer under your name by logging in or signing up, or post anonymously.

Still have a question? Ask a question here publicly — for free.

Or talk to one of our consultants — first calls are free. Check out our services and prices.

Looking to automate your regulatory work? Check out our eQMS, Formwork. Built for lean, founder-led companies. There’s a free version too.